Founded in 2012, Neurotrack is a digital health company dedicated to the development of non-invasive cognitive health assessment tools that will enable earlier and more effective evaluation of patients who may be at risk for cognitive decline, and help advance research of treatments for cognitive diseases, including Alzheimer's. Neurotrack's process starts with the assessment of the user's memory health using the company's proprietary eye tracking technology called Imprint Memory Assessment. From there, the service helps users incorporate behaviors that keep their memory sharp, while also providing them with the ability to track their progress. Neurotrack works with the world's leading scientists to bring users the latest technology to improve their memory health. Its service costs $99 per test and can also be covered by insurance.
Select investors Khosla Ventures, Social Capital, Founders Fund, Sozo Ventures, Marc Benioff, AME Cloud Ventures, Rethink Impact, iSeed Ventures, Rock Health
Last update: May 20, 2018
Disclaimer: We can not guarantee that the information on this page is 100% correct. more